SULF1 and carcinoma: Similarly, even though silencing of SULF1 has been mostly associated with poor prognosis in a variety of carcinomas [33, 51–53], we hypothesize that these outcomes rely heavily on the signaling context, such as type of tumor, disease stage, spatial distribution of GAGases, specific ligands, and other factors [32].